Pembrolizumab as a first-line treatment for advanced gastric cancer

被引：1
|
作者：
Chau, Ian [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton, England
来源：
LANCET ONCOLOGY | 2023年 / 24卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(23)00526-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1158 / 1159
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab (Keytruda) for First-Line Treatment of Metastatic NSCLC
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1513): : 4 - 5
  • [42] POSTPROGRESSION SURVIVAL FOR FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Kawakami, H.
    Okamoto, I.
    Hayashi, H.
    Taguri, M.
    Morita, S.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 95 - 95
  • [43] Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer
    Kawakami, Hisato
    Okamoto, Isamu
    Hayashi, Hidetoshi
    Taguri, Masataka
    Morita, Satoshi
    Nakagawa, Kazuhiko
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 3003 - 3009
  • [44] Molecular-targeted first-line therapy for advanced gastric cancer
    Song, Huan
    Zhu, Jianwei
    Lu, DongHao
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (07):
  • [45] FIRST-LINE MAINTENANCE AND SECOND-LINE TREATMENT OF ADVANCED OR METASTATIC GASTRIC CANCER: A SYSTEMATIC REVIEW OF LITERATURE
    Singh, B.
    Attri, S.
    Kaur, G.
    Flynn, J.
    VALUE IN HEALTH, 2020, 23 : S421 - S421
  • [46] Ramucirumab efficacy in first-line gastric and esophageal cancer treatment
    Longo, Federico
    Reguera, Pablo
    Carrato, Alfredo
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S617 - S621
  • [47] Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer
    Punt, Cornelis J. A.
    Koopman, Miriam
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1907 - 1908
  • [48] Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
    Punt, CJA
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 845 - 846
  • [49] Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first-line treatment for advanced esophageal cancer
    Ye, Zhuo-Miao
    Xu, Zhe
    Wang, Hao-Lun
    Wang, Ying-Yuan
    Chen, Ze-Chang
    Zhou, Qin
    Li, Xiang-Ping
    Zhang, Ying-Ying
    CANCER MEDICINE, 2023, 12 (05): : 6182 - 6189
  • [50] Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
    Tibaldi, Carmelo
    Mazzoni, Francesca
    Scotti, Vieri
    Vasile, Enrico
    Pozzessere, Daniele
    Stasi, Irene
    Camerini, Andrea
    Federici, Francesca
    Meoni, Giulia
    Caparello, Chiara
    Turrini, Marianna
    Rossi, Virginia
    Ciccone, Lucia Pia
    Pecora, Irene
    Fantechi, Beatrice
    Antonuzzo, Lorenzo
    Giannarelli, Diana
    Baldini, Editta
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (07) : 1278 - 1285
12345